Fate Therapeutics
Top stories
Latest
- Analyzing Fate Therapeutics (NASDAQ:FATE) and Syndax Pharmaceuticals (NASDAQ:SNDX)themarketsdaily.com · 2026-10-03 13:06 UTC · story
- Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — all · 2026-10-02 11:00 UTC · story